Pseudomonas aeruginosa: a formidable and ever-present adversary - PubMed (original) (raw)
Review
Pseudomonas aeruginosa: a formidable and ever-present adversary
K G Kerr et al. J Hosp Infect. 2009 Dec.
Abstract
Pseudomonas aeruginosa is a versatile pathogen associated with a broad spectrum of infections in humans. In healthcare settings the bacterium is an important cause of infection in vulnerable individuals including those with burns or neutropenia or receiving intensive care. In these groups morbidity and mortality attributable to P. aeruginosa infection can be high. Management of infections is difficult as P. aeruginosa is inherently resistant to many antimicrobials. Furthermore, treatment is being rendered increasingly problematic due to the emergence and spread of resistance to the few agents that remain as therapeutic options. A notable recent development is the acquisition of carbapenemases by some strains of P. aeruginosa. Given these challenges, it would seem reasonable to identify strategies that would prevent acquisition of the bacterium by hospitalised patients. Environmental reservoirs of P. aeruginosa are readily identifiable, and there are numerous reports of outbreaks that have been attributed to an environmental source; however, the role of such sources in sporadic pseudomonal infection is less well understood. Nevertheless there is emerging evidence from prospective studies to suggest that environmental sources, especially water, may have significance in the epidemiology of sporadic P. aeruginosa infections in hospital settings, including intensive care units. A better understanding of the role of environmental reservoirs in pseudomonal infection will permit the development of new strategies and refinement of existing approaches to interrupt transmission from these sources to patients.
Comment in
- Problems with pseudomonas.
McLellan E, Tomlin K. McLellan E, et al. J Hosp Infect. 2010 May;75(1):75-6. doi: 10.1016/j.jhin.2009.12.009. Epub 2010 Mar 15. J Hosp Infect. 2010. PMID: 20227786 No abstract available.
Similar articles
- [Nosocomial infections caused by Pseudomonas aeruginosa: Exogenous or endogenous origin of this bacterium?].
Floret N, Bertrand X, Thouverez M, Talon D. Floret N, et al. Pathol Biol (Paris). 2009 Feb;57(1):9-12. doi: 10.1016/j.patbio.2008.07.011. Epub 2008 Oct 9. Pathol Biol (Paris). 2009. PMID: 18848405 French. - Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Yetkin G, et al. Am J Infect Control. 2006 May;34(4):188-92. doi: 10.1016/j.ajic.2005.11.010. Am J Infect Control. 2006. PMID: 16679175 - Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y, Otlu B, Dogukan M, Gursoy C, Korkmaz E, Kizirgil A, Ozden M, Durmaz R. Yakupogullari Y, et al. Am J Infect Control. 2008 Dec;36(10):e13-8. doi: 10.1016/j.ajic.2008.07.006. Am J Infect Control. 2008. PMID: 19084158 Clinical Trial. - Risk assessment of Pseudomonas aeruginosa in water.
Mena KD, Gerba CP. Mena KD, et al. Rev Environ Contam Toxicol. 2009;201:71-115. doi: 10.1007/978-1-4419-0032-6_3. Rev Environ Contam Toxicol. 2009. PMID: 19484589 Review. - Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism.
Trautmann M, Lepper PM, Haller M. Trautmann M, et al. Am J Infect Control. 2005 Jun;33(5 Suppl 1):S41-9. doi: 10.1016/j.ajic.2005.03.006. Am J Infect Control. 2005. PMID: 15940115 Review.
Cited by
- Molecular Detection of Drug-Resistance Genes of _bla_OXA-23_-bla_OXA-51 and mcr-1 in Clinical Isolates of Pseudomonas aeruginosa.
Nitz F, de Melo BO, da Silva LCN, de Souza Monteiro A, Marques SG, Monteiro-Neto V, de Jesus Gomes Turri R, Junior ADS, Conceição PCR, Magalhães HJC, Zagmignan A, Ferro TAF, Bomfim MRQ. Nitz F, et al. Microorganisms. 2021 Apr 9;9(4):786. doi: 10.3390/microorganisms9040786. Microorganisms. 2021. PMID: 33918745 Free PMC article. - The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes.
Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K. Balasubramanian D, et al. PLoS One. 2012;7(3):e34067. doi: 10.1371/journal.pone.0034067. Epub 2012 Mar 29. PLoS One. 2012. PMID: 22479525 Free PMC article. - Pseudomonas aeruginosa in premise plumbing of large buildings.
Bédard E, Prévost M, Déziel E. Bédard E, et al. Microbiologyopen. 2016 Dec;5(6):937-956. doi: 10.1002/mbo3.391. Epub 2016 Jun 28. Microbiologyopen. 2016. PMID: 27353357 Free PMC article. Review. - Phenylethanoid Glycosides: Research Advances in Their Phytochemistry, Pharmacological Activity and Pharmacokinetics.
Xue Z, Yang B. Xue Z, et al. Molecules. 2016 Jul 29;21(8):991. doi: 10.3390/molecules21080991. Molecules. 2016. PMID: 27483229 Free PMC article. Review. - Unraveling the antimicrobial potential of Lactiplantibacillus plantarum strains TE0907 and TE1809 sourced from Bufo gargarizans: advancing the frontier of probiotic-based therapeutics.
Huang F, Zhao Y, Hou Y, Yang Y, Yue B, Zhang X. Huang F, et al. Front Microbiol. 2024 Feb 14;15:1347830. doi: 10.3389/fmicb.2024.1347830. eCollection 2024. Front Microbiol. 2024. PMID: 38419633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources